多种治疗手段在中、重度慢性阻塞性肺疾病合并焦虑或忧郁治疗中的应用及对比

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To compare the application effect of various treatment methods in the treatment of moderate and severe chronic obstructive pulmonary disease with anxiety or depression.Methods From January 2017 to November 2019,150 patients with moderate or severe chronic obstructive pulmonary disease combined with anxiety or depression were selected from Jingdezhen First People′s Hospital.They were divided into three groups by random number table method,50 cases in each group.Group A was treated with primary disease drugs + psychological counseling,group B was treated with primary disease drugs + adjuvant therapy with psychotropic drugs,group C was treated with psychological counseling + primary disease drugs + adjuvant therapy with psychotropic drugs.The clinical effect,anxiety and depression degree,lung function before and 6 months after treatment were compared among the three groups.Results The total clinical effective rate of group C (98.00%) was higher than that of group A (78.00%) and group B and(82.00%),the difference was statistically significant (P＜0.05).There were no significant differences in Hamilton anxiety scale (HAMA) score and Hamilton depression scale (HAMD) score among the three groups before treatment (P＞0.05).The HAMA score and HAMD score of group C after treatment were (8.03±1.51) points and (9.17±2.03) points,respectively,which were lower than those of group A ([12.21±3.01],[13.06±3.16]points) and group B ([11.62±2.26],[11.21±2.54]points),with statistically significant differences (P＜0.05).There were no significant differences among the three groups in the forced expiratory volume at 1 second(FEV1),the ratio of FEV1 to the expected value (FEV1%),the ratio of FEV1 to the forced vital capacity (FEV1/FVC) (P＞0.05).After treatment,FEV1 in group C was (2.21±0.65) L,FEV1% was (53.74±7.93),and FEV1/FVC was (58.55±6.64)%,higher than those in group A ([1.78±0.38]L,[46.51±7.41],[55.79±6.59]%) and group B ([1.89±0.49]L,[48.26±7.62],[55.83±6.32]%),with statistically significant differences (P＜0.05).Conclusion Psychological counseling + primary disease drugs + adjuvant therapy with psychotropic drugs are effective in the treatment of moderate and severe chronic obstructive pulmonary disease with anxiety or depression,which can improve the degree of anxiety and depression and lung function,improve the treatment effect,and promote the recovery of patients′ disease.

Key words： Chronic obstructive pulmonary disease Anxiety Depression Pulmonary function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FENG Xuan
	LE Liang
	NI Hong-yan

Cite this article:

FENG Xuan,LE Liang,NI Hong-yan. Application and comparison of various treatment methods in the treatment of moderate and severe chronic obstructive pulmonary disease with anxiety or depression[J]. 中国当代医药, 2020, 27(35): 44-47.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2020/V27/I35/44

[1]	符沙沙，陈宗存，欧宗兴，等.维生素D 对慢性阻塞性肺疾病合并肺动脉高压患者焦虑、抑郁及生活质量的影响[J].中国现代医学杂志，2019，29（14）：60-64.
[2]	郭利利，苏迪，徐梦林，等.吸入药物对慢性阻塞性肺疾病患者焦虑和抑郁情绪影响的研究[J].临床肺科杂志，2017，22（4）：653-658.
[3]	雷震，林荣，孙传忠，等.肺康复治疗辅以情绪管理对改善慢性阻塞性肺疾病抑郁状态、肺功能的影响[J].中华全科医学，2018，16（1）：1769-1772.
[4]	中华医学会，中华医学会杂志社，中华医学会全科医学分会，等.慢性阻塞性肺疾病基层诊疗指南（实践版·2018）[J].中华全科医师杂志，2018，17（11）：871.
[5]	王志芬.提高中医护理干预水平对老年COPD 患者HAMA 和HAMD评分的影响[J].河北医药，2016，38（11）：1739-1741.
[6]	刘贤兵，李芳，陈晓萍.慢性阻塞性肺疾病患者合并周围神经病变情况及临床意义研究[J].中国全科医学，2018，21（23）：2808-2813.
[7]	黄效梅，周丹.肺康复训练对缓解高龄慢性阻塞性肺疾病患者焦虑及抑郁的效果分析[J].检验医学与临床，2018，15（8）：148-151.
[8]	徐颖臻，潘瑞丽，赵迪，等.基于知信行模式的3H 护理对慢性阻塞性肺疾病合并抑郁症患者负性情绪及生活质量的影响[J].国际精神病学杂志，2019，46（2）：371-373.
[9]	常建萍，刘永德，王新绘.系统护理结合情志护理对慢性阻塞性肺疾病患者负面情绪及生命质量的影响[J].西部中医药，2018，31（8）：140-142.
[10]	辛晓燕，耿莹，李宪红，等.延续护理对老年慢性阻塞性肺疾病患者心理健康和自我护理能力的影响[J].现代中西医结合杂志，2018，27（36）：109-112.
[11]	周爱华.综合护理干预对老年慢性阻塞性肺疾病稳定期病人肺功能、心理状态及睡眠质量的影响[J].护理研究，2018，32（21）：153-156.
[12]	郭欣，李玉超，刘震宇.氟哌噻吨美利曲辛片对慢性阻塞性肺疾病合并焦虑抑郁症状患者的临床影响[J].中华老年多器官疾病杂志，2019，18（7）：523-526.
[13]	陈晓燕，李啸.氟哌噻吨美利曲辛联合心理干预在慢性阻塞性肺疾病伴焦虑抑郁患者中的应用效果[J].中国医药导报，2017，14（13）：65-68.
[14]	郭荣荣.心理护理对老年慢性阻塞性肺疾病患者生活质量与抑郁焦虑状态的影响[J].中国药物与临床，2019，19（16）：2879-2881.
[15]	龚放华，杨燕妮，张婷.心肺康复训练对稳定期老年COPD患者心肺功能、生活质量及心理状况的影响[J].医学临床研究，2017，34（9）：1746-1748.
[16]	颜沃志，麦伟忠，谭英强.慢性阻塞性肺疾病急性加重期患者肺功能与血气分析、炎症指标的关系分析[J].中国医药科学，2019，9（24）：268-270.
[17]	林明江，汤秀珍，梁锦泉.布地奈德福莫特罗吸入剂联合肺康复训练治疗中重度COPD 疗效研究[J].中国医药科学，2018，8（4）：30-32，36.
[18]	郭晓燕，腾飞，张惠勇.川芎平喘合剂治疗慢性阻塞性肺疾病的随机对照研究[J].西部中医药，2018，31（1）：1-4.